Home / News / India News / Article /
'India's first homegrown mRNA vaccine to be tested amid Omicron spike'
Updated On: 17 January, 2022 02:18 PM IST | New Delhi | ANI
Gennova Biopharmaceuticals has also developed the mRNA vaccine for the Omicron variant that will be tested on humans for efficacy and immunogenicity soon
Listen to this article :
This picture has been used for representational purpose
The country`s first messenger mRNA vaccine is expected to begin trials on humans in February.
The Pune-based Gennova Biopharmaceuticals has submitted phase 2 data of mRNA vaccine and has also completed the recruitment of phase 3 data. Drugs Controller General of India`s (DCGI) Subject Expert Committee (SEC) is expected to review the data soon, the official sources said.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT